Association between hepatitis B virus core promoter rearrangements and hepatocellular carcinoma

Biochemical and Biophysical Research Communications
T LaskusJ Rakela

Abstract

Hepatitis B virus (HBV) is the major etiological agent of hepatocellular carcinoma (HCC). Whether any particular viral variants are associated with HCC is unknown. We studied 53 Gambian patients with HCC and 33 HBsAg positive controls. A functional part of HBV core promoter and whole precore region were sequenced directly and/or after cloning. HBV DNA was amplified from sera from 27 HCC patients and in all controls. Fourteen (52%) patients and 12 (36%) controls (NS) were found to harbor an HBV strain with G to A transition mutation at position 1896 leading to HBeAg negative phenotype. Nine (33%) HCC patients and 2 (6%) controls (p < 0.01) harbored a mixture of wild type and HBV strains with deletions/insertions; strong consensus sequences for topoisomerase I breakage were located in the vicinity of these changes. In Africa, HCC is associated with HBV strains that have deletions/insertions in the HBV core promoter region.

References

May 1, 1991·Journal of Virology·H P Wang, C E Rogler
Jun 13, 1991·The New England Journal of Medicine·T J LiangE Ben-Porath
Jan 1, 1985·Annual Review of Biochemistry·J C Wang

❮ Previous
Next ❯

Citations

Dec 11, 1999·Proceedings of the Association of American Physicians·D W Bradley
Jul 4, 2009·Journal of the National Cancer Institute·Shijian LiuGuangwen Cao
Sep 10, 1999·Reviews in Medical Virology·S L NguiC G Teo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.